Compare Bajaj Finance with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAJAJ FINANCE vs INDOCO REMEDIES - Comparison Results

BAJAJ FINANCE     Change

Established in 1987, Bajaj Finance Ltd is a subsidiary of Bajaj Finserv Ltd, the financial services arm of the Bajaj Group. In the early days, Bajaj Finance provided loans for two and three-wheelers manufactured by Bajaj Auto Ltd. Over the years, the... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAJAJ FINANCE INDOCO REMEDIES BAJAJ FINANCE/
INDOCO REMEDIES
 
P/E (TTM) x 24.1 64.7 37.3% View Chart
P/BV x 7.2 2.9 246.2% View Chart
Dividend Yield % 0.2 0.5 38.7%  

Financials

 BAJAJ FINANCE   INDOCO REMEDIES
EQUITY SHARE DATA
    BAJAJ FINANCE
Mar-18
INDOCO REMEDIES
Mar-18
BAJAJ FINANCE/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,989317 626.7%   
Low Rs1,153178 647.2%   
Sales per share (Unadj.) Rs1,168.6113.1 1,033.5%  
Earnings per share (Unadj.) Rs232.54.5 5,204.6%  
Cash flow per share (Unadj.) Rs241.311.8 2,042.8%  
Dividends per share (Unadj.) Rs4.001.00 400.0%  
Dividend yield (eoy) %0.30.4 63.1%  
Book value per share (Unadj.) Rs1,438.473.2 1,963.7%  
Shares outstanding (eoy) m115.0392.15 124.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.32.2 61.3%   
Avg P/E ratio x6.855.5 12.2%  
P/CF ratio (eoy) x6.521.0 31.0%  
Price / Book Value ratio x1.13.4 32.3%  
Dividend payout %1.722.4 7.7%   
Avg Mkt Cap Rs m180,68922,830 791.4%   
No. of employees `00015.35.5 279.9%   
Total wages/salary Rs m14,1962,209 642.6%   
Avg. sales/employee Rs Th8,805.21,910.1 461.0%   
Avg. wages/employee Rs Th929.9405.0 229.6%   
Avg. net profit/employee Rs Th1,751.775.5 2,321.5%   
INCOME DATA
Net Sales Rs m134,42010,419 1,290.1%  
Other income Rs m23947 509.0%   
Total revenues Rs m134,65910,466 1,286.6%   
Gross profit Rs m88,0871,349 6,528.4%  
Depreciation Rs m1,021677 150.7%   
Interest Rs m46,343235 19,712.2%   
Profit before tax Rs m40,962484 8,463.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m14,22172 19,642.1%   
Profit after tax Rs m26,741412 6,496.9%  
Gross profit margin %65.512.9 506.0%  
Effective tax rate %34.715.0 232.1%   
Net profit margin %19.94.0 503.6%  
BALANCE SHEET DATA
Current assets Rs m377,8065,373 7,031.7%   
Current liabilities Rs m227,4584,157 5,471.8%   
Net working cap to sales %111.811.7 958.4%  
Current ratio x1.71.3 128.5%  
Inventory Days Days068 0.0%  
Debtors Days Days93273 1,280.5%  
Net fixed assets Rs m4,6706,244 74.8%   
Share capital Rs m1,150184 624.1%   
"Free" reserves Rs m164,3066,566 2,502.6%   
Net worth Rs m165,4576,750 2,451.3%   
Long term debt Rs m458,9631,233 37,229.3%   
Total assets Rs m868,24312,363 7,023.1%  
Interest coverage x1.93.1 61.6%   
Debt to equity ratio x2.80.2 1,518.8%  
Sales to assets ratio x0.20.8 18.4%   
Return on assets %8.45.2 160.9%  
Return on equity %16.26.1 265.0%  
Return on capital %14.09.0 155.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m03,762 0.0%   
Fx outflow Rs m3151,143 27.6%   
Net fx Rs m-3152,619 -12.0%   
CASH FLOW
From Operations Rs m-204,6141,227 -16,673.2%  
From Investments Rs m9,712-1,360 -714.0%  
From Financial Activity Rs m195,033-388 -50,305.1%  
Net Cashflow Rs m131-521 -25.1%  

Share Holding

Indian Promoters % 61.6 59.2 104.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.1 12.5 56.8%  
FIIs % 12.2 6.0 203.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.1 22.4 85.3%  
Shareholders   19,952 12,805 155.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAJAJ FINANCE With:   INGERSOLL RAND  CHOLAMANDALAM INVEST.  EDELWEISS FINANCIAL  NALWA SONS INV  CREST VENTURES  



Today's Market

Sensex Ends 674 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day and ended lower. Investors were worried about the economic impact and uncertainty over the coronavirus pandemic.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (3QFY20); Net Profit Up 74.9% (Quarterly Result Update)

Jan 27, 2020 | Updated on Jan 27, 2020

For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

BAJAJ FINANCE Announces Quarterly Results (2QFY20); Net Profit Up 63.1% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, BAJAJ FINANCE has posted a net profit of Rs 15 bn (up 63.1% YoY). Sales on the other hand came in at Rs 63 bn (up 48.5% YoY). Read on for a complete analysis of BAJAJ FINANCE's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

BAJAJ FINANCE Announces Quarterly Results (1QFY20); Net Profit Up 43.0% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, BAJAJ FINANCE has posted a net profit of Rs 12 bn (up 43.0% YoY). Sales on the other hand came in at Rs 58 bn (up 47.4% YoY). Read on for a complete analysis of BAJAJ FINANCE's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

One Stock that is All Charged Up for the Post Coronavirus Rebound(The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

BAJAJ FINANCE SHARE PRICE


Apr 3, 2020 (Close)

TRACK BAJAJ FINANCE

  • Track your investment in BAJAJ FINANCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BAJAJ FINANCE 8-QTR ANALYSIS

COMPARE BAJAJ FINANCE WITH

MARKET STATS